All News
Filter News
Found 463 articles
-
Portage Biotech's Biohaven's Lead Drug Candidate Clears FDA Investigational New Drug Application (IND) Review And Clinical Studies To Begin
8/24/2015
-
Portage Biotech's Biohaven Acquires Intellectual Property For Portfolio Of Prodrugs From ALS Biopharma LLC
8/18/2015
-
Portage Biotech's Biohaven Raises $ 4.1 Million In First Tranche Of Private Placement. Portage Invests $ 2.5 Million
8/11/2015
-
Portage Biotech Invests In Sentien Biotechnologies Inc.
8/10/2015
-
Portage Biotech's Biohaven Announces IND Filing For Bhv-0223 For Phase 1 Clinical Testing
7/23/2015
-
Portage Biotech Completes Non-Brokered Private Placement In Two Tranches For A Total Proceeds Of US$ 5,155,080
6/25/2015
-
Portage Biotech Announces Proposed Private Placement
5/20/2015
-
Portage Biotech's Biohaven To Begin Phase 1 Study In 3Q2015 And Readying For Phase 3 Study Start By 1Q2016
4/22/2015
-
Portage Biotech's CPP Platform Delivers A Peptide Cargo Across Blood Brain Barrier
4/20/2015
-
Portage Biotech To Present At Master Investor 2015 In London, UK
4/16/2015
-
Portage Biotech's Biohaven Announces Agreement With inVentiv Health
4/1/2015
-
Portage Biotech's Biohaven Enters Into Exclusive Formulation Agreement And Global License With Catalent Pharma Solutions For Lead Product
3/24/2015
-
Portage's Biohaven Receives Response From FDA To Its Pre-IND Meeting Request
12/18/2014
-
Portage Announces Further Successful Validation Of Its New Proprietory Cell Permeable Peptide Platform Technology
12/16/2014
-
Portage Completes Non-Brokered Private Placement For A Total Proceeds Of US$2,000,000
10/16/2014
-
Portage Biotech Announces Additional Consultants To Expedite Its PPL-003 Development Programs
10/6/2014
-
Portage Announces Conversion Of Its Debt Into Equity
9/30/2014
-
Portage Announces New Consultants For Its PPL-003 Development Programs
9/23/2014
-
Mergers Hamper Innovation, Ex-Pfizer Top Exec Says
9/11/2014
-
Portage Announces Proposed Private Placement
9/11/2014